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ABSTRACT
The presence of methicillin resistant Staphylococcus aureus (MRSA) on environmental
surfaces in healthcare facilities pre-and post- cleaning
by
Aaron Thomas Hunt
Mark Buttner, Ph.D., Committee Chair
Professor, Department of Environmental and Occupational Health
School of Community Health Sciences
University of Nevada, Las Vegas

The emergence of antibiotic resistant bacteria is a serious public health issue
affecting millions of people. Methicillin-resistant Staphylococcus aureus (MRSA) is a
leading cause of healthcare acquired infections today. Research has shown that patients
infected or colonized with MRSA shed the bacteria into the environment, where the
bacteria can survive for long periods of time and become potential sources of infection.
Currently, infection prevention efforts focus on active surveillance, hand hygiene,
personal protective equipment use and antimicrobial stewardship, with less attention
given to environmental cleaning. Nevertheless, environmental cleaning is essential to
remove infectious agents from environmental surfaces and prevent transmission. The
purpose of this study was to examine the effectiveness of environmental cleaning
programs in removing MRSA from environmental surfaces at an acute care hospital and
a long-term care facility. Environmental swabs or sponge samples were collected from
five locations (floor, television remote, call bell, bathroom doorknob and bed rail) pre-
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and post-terminal cleaning from the rooms of patients infected or colonized with MRSA.
These swabs or sponges were then analyzed through culture isolation and polymerase
chain reaction (PCR) to confirm the presence of MRSA. A total of 120 environmental
samples were obtained from two medical facilities. Culture analysis followed by
confirmatory PCR analysis for the mecA gene showed that 18 of the 120 samples (15%)
were positive for the presence of MRSA of which 16 were collected pre-cleaning (89%),
and 2 were collected post-cleaning (11%). The location of the positive pre-cleaning
samples included the floor (5), call bell (4), bed rail (4), bathroom doorknob (2) and TV
remote (1), and the positive post-cleaning samples included the floor (1) and call bell
(1). The results confirm the presence of MRSA on surfaces in patient rooms and suggest
that environmental cleaning was effective, but there is potential for rooms to remain
contaminated. Future research should focus on identifying the most effective cleaning
programs to ensure rooms are safe for patients.
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CHAPTER 1
BACKGROUND
Throughout much of human history, bacterial infections have been a leading
cause of death. Before the discovery of antibiotics, the mortality rate from bacteremia
caused by Staphylococcus aureus was above 80% (Skinner & Keefer, 1941). This began to
change in 1928, when Alexander Fleming discovered penicillin, the first antibiotic (Ligon,
2004). For the first time, humans had an effective way to treat bacterial infections. This
discovery saved millions of lives and changed science forever. Unfortunately, the
success did not last. Bacteria rapidly developed resistance to penicillin, and it became
clear that researchers were going to have to develop new types of antibiotics and
understand the mechanisms of antimicrobial resistance to control infections (Chambers
& Deleo, 2009).
The emergence of antimicrobial resistant bacteria is a serious public health issue
affecting millions of people worldwide. Today, one of the most common types of
antimicrobial resistant bacteria is methicillin-resistant Staphylococcus aureus (MRSA).
This bacterium is commonly referred to as “staph” and is a leading source of healthcare
acquired infection in the United States and many other countries (Diekema et al., 2001).
Based on prevalence rates in 2005, it has been estimated that there are 1,300,000 MRSA
infections per year in the United States alone (Klevens et al., 2007). This is noteworthy
because, when compared to infections caused by methicillin susceptible Staphylococcus
aureus (MSSA) strains, MRSA infections have been demonstrated to be more difficult to

1

treat, increase morbidity and mortality rates, and increase medical costs (Filice et al.,
2010).
Since MRSA was first identified, it has undergone several fundamental changes.
Initially, infections caused by MRSA were primarily observed in populations that had
been exposed to healthcare facilities and were thought to be a nosocomial problem
(David & Daum, 2010). This began to change during the 1990s, when infections caused
by MRSA began to emerge in the community in healthy populations with no exposure to
healthcare facilities or other risk factors (Berman, Eisner, & Kreiswirth, 1993; Dammann,
Wiens, & Taylor, 1988; Nimmo & Coombs, 2008; Pate, Nolan, Bannerman, & Feldman,
1995). This new type of community-acquired MRSA substantially increased the number
of infections and quickly spread across the globe.
Both healthcare-associated MRSA (HA-MRSA) and community-associated MRSA
(CA-MRSA) are a leading cause of healthcare-associated infections (HAIs) in acute-care
hospitals (ACH) and long-term care facilities (LTCF). MRSA infections remain a chief
focus of infection prevention programs. Currently, MRSA prevention efforts have
focused on populations with high prevalence of MRSA infections and healthcare
facilities. Infection prevention efforts at healthcare facilities have focused on improving
active surveillance to identify infected or colonized patients, hand hygiene, the use of
personal protective equipment, and antimicrobial stewardship, with less attention given
to environmental cleaning. Nevertheless, none of these prevention tools are effective
alone, and environmental cleaning is essential in controlling the spread of bacteria
(Otter, Yezli, & French, 2011). Research has shown that patients infected or colonized
2

with MRSA shed the bacteria into the environment (Boyce, Potter-Bynoe, Chenevert, &
King, 1997; French et al., 2004; Sexton, Clarke, O'Neill, Dillane, & Humphreys, 2006),
where the bacteria can survive for long periods of time (Kramer, Schwebke, & Kampf,
2006). These bacteria that are shed onto environmental surfaces become potential
sources of infection for susceptible patients who spend time in healthcare facilities. Few
studies have been conducted to determine the effectiveness of environmental cleaning
in removing MRSA from different environmental surfaces in healthcare facilities.
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CHAPTER 2
INTRODUCTION
Emergence of Antimicrobial Resistant Bacteria
It is essential to understand how antimicrobials act before examining the
mechanisms of antimicrobial resistance. In general, antimicrobials inhibit bacterial
infection by disrupting essential actions in the bacteria, including (1) cell wall synthesis,
(2) protein synthesis, (3) nucleic acid synthesis, and (4) metabolic pathways (Neu, 1992).
If an antimicrobial can inhibit, stop or alter any of these essential functions, the
bacterium will be disabled or will die.
The first antimicrobial resistant bacteria were observed shortly after the clinical
implementation of penicillin (Forbes, 1949; Kirby, 1944). During this time, researchers
knew little about the mechanisms of resistance, but over the past 50 years scientific
understanding has tremendously increased. It is now known that bacteria have the
ability to develop resistance to antimicrobials through two main mechanisms: (1)
natural selection of spontaneous mutations in their DNA, and (2) the incorporation of
genetic material into their DNA from other bacteria (Tenover, 2006).
Spontaneous mutations commonly occur in bacteria, and occasionally the new
mutation will result in the development of resistance to antimicrobials. A good example
of this mechanism occurs in penicillin-resistant pneumococci, which have evolved
resistance due to a mutation that alters the binding site for penicillin, making it
ineffective (Contreras-Martel, Dahout-Gonzalez, Martins Ados, Kotnik, & Dessen, 2009).
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Bacteria can also develop resistance by obtaining genetic material that encodes
the resistance trait from bacteria of the same species or from different species. This
genetic material can be obtained through transformation, conjugation or transduction
(McManus, 1997; Tenover, 2006). Transformation occurs when bacteria obtain genetic
material released from cells, often through cell lysis, and is present in the environment.
Conjugation occurs when plasmids, mobile genetic elements, are directly transferred
between two organisms. This can occur by mechanisms such as a pilus, which can
connect two cells, or when cells conjoin during sexual reproduction. Transduction occurs
when genes are transferred between bacteria by a bacteriophage, which is a virus that
infects bacteria and can occasionally transfer genetic material.
Both mechanisms of resistance have been enhanced by the misuse and overuse
of antibiotics (Chambers & Deleo, 2009). Antimicrobial use increases the development
of resistance strains of bacteria because the antimicrobial will kill all the naturally
susceptible bacteria. This allows only the bacteria that have developed resistance to
survive and multiply. Current infection prevention efforts are focusing on antimicrobial
stewardship to limit the misuse of antimicrobials.
Overall, bacteria have been extraordinarily successful at developing resistance to
antimicrobials. Several species of antimicrobial resistant bacteria have become endemic
in healthcare facilities, including staphylococci, enterococci, Klebsiella pneumonia, and
Pseudomonas ("National Nosocomial Infections Surveillance [NNIS] System Report, data
summary from January 1992 through June 2004, issued October 2004," 2004).
Additionally, many organisms have now become resistant to multiple types of drugs,
5

including MRSA, vancomycin-resistant enterococci and several gram-negative bacilli.
These multi-drug resistant organisms are particularly of concern because there are
seriously limited treatment options. What is most alarming is that some of the extended
spectrum β-lactamase producing bacteria have been shown to be resistant to all
currently available antimicrobial agents (Siegel, Rhinehart, Jackson, & Chiarello, 2007).
Methicillin Resistant Staphylococcus aureus (MRSA)
Staphylococcus aureus is a ubiquitous bacterium that has plagued humans for
thousands of years. S. aureus is a gram positive bacterium that is part of the
Micrococcaceae family and can be characterized by its spherical shape and golden color.
It can grow in both aerobic and anaerobic conditions and is often identified through
positive coagulase, mannitol-fermentation and deoxyribonuclease test results (Lowy,
1998; Mahon & Manuselis, 1995).
It is necessary to note that S. aureus is naturally susceptible to all antimicrobials,
but it is also exceptionally efficient in developing resistance. The first strains of
antimicrobial resistant S. aureus were observed shortly after the introduction of
penicillin for clinical use (Kirby, 1944). These strains became resistant to penicillin by
producing a plasmid-encoded penicillinase, called β-lactamase that can break down the
β-lactam ring of penicillin, making it ineffective (Chambers & Deleo, 2009).
Researchers had to create new antimicrobials to combat this new penicillin
resistant organism, and were able to do so when they created a new synthetic penicillin
called methicillin. Methicillin helped control the penicillin resistant strains, but the
success did not last. In 1961, the first methicillin-resistant Staphylococcus aureus (MRSA)
6

strains were identified (Barber, 1961; Jevons, 1961). Interestingly, this was only two
years after the introduction of methicillin.
Today, it is known that MRSA is a subclass of S. aureus that has developed
resistance to several classes of antibiotics including penicillins, cephalosporins and
carbapenems (Chambers & Deleo, 2009). Research has shown that methicillin
susceptible S. aureus (MSSA) is able to develop resistance to antimicrobials containing a
β-lactam ring because of its ability to acquire the resistance encoding mecA gene. The
mecA gene is acquired from a mobile genetic element from other Staphylococcus
species, which naturally contain this resistance gene (Moellering, 2012). The mecA gene
produces resistance because it encodes the penicillin binding protein 2a (PBP 2a), which
improves cell wall synthesis in the presence of β-lactam antimicrobials (Hartman &
Tomasz, 1984; Song, Wachi, Doi, Ishino, & Matsuhashi, 1987; Utsui & Yokota, 1985).
Genetic analysis of MRSA has found that the mecA gene is carried on a mobile
genetic element that researchers have named the staphylococcal cassette chromosome
mec (SCCmec) (Katayama, Ito, & Hiramatsu, 2000). Currently, there are nine different
types of SCCmec elements (types I-VIII and VT) that have been identified (David & Daum,
2010). While all of these nine mobile cassettes contain the complete mecA gene, each
has a slightly different genetic makeup that can change gene expression, virulence and
other characteristics. Bacteria can be characterized below the species level by strain
typing, which identifies differences in the DNA between bacteria of the same species.
One important variable genetic element that several of the strains of MRSA carry
is the Panton-Valentine leukocidin (PVL) gene. This gene is found in many community7

associated MRSA strains and is thought to increase virulence by destroying leukocytes
and causing inflammation, but more evidence is needed to confirm this theory (Colin,
Mazurier, Sire, & Finck-Barbancon, 1994; Kaneko, Kimura, Narita, Tomita, & Kamio,
1998; Meyer, Girardot, Piemont, Prevost, & Colin, 2009). Another key genetic variant in
MRSA strains is the arginine catabolic mobile element (ACME). This element is unique to
the community-associated MRSA strain USA300. The importance of the ACME is that it
contains several arc genes that improve the fitness of the bacterium, which may result
in strains that are more difficult to treat and control (Diep, Stone, et al., 2008).
Epidemiology of MRSA
When MRSA initially emerged, it was regarded as a nosocomial pathogen, which
only infected people who had been exposed to healthcare facilities or had other risk
factors such as drug abuse (David & Daum, 2010). This type of MRSA was later named
healthcare-associated or healthcare-acquired MRSA (HA-MRSA). Several strains of HAMRSA eventually spread across the globe with a strong prevalence in North America,
South America, Europe and Asia (Diekema et al., 2001; Stefani et al., 2012). It is
beneficial to note that the prevalence of HA-MRSA varies widely based on geographic
locations, which researchers think is due to the success of prevention and eradication
programs (Andersen, Rasch, & Syversen, 2007; Dulon, Haamann, Peters, Schablon, &
Nienhaus, 2011; Kerttula et al., 2007; Moellering, 2012). Nevertheless, HA-MRSA quickly
became a global health problem and remains one today.
The isolation of MRSA to healthcare facilities began to change in the 1990s,
when MRSA infections were first identified in healthy people who lacked exposure to
8

healthcare facilities or other risk factors (David & Daum, 2010). Upon further analysis, it
was discovered that new strains of MRSA had emerged. These strains were later named
community-associated or community-acquired MRSA (CA-MRSA) due to their presence
in healthy communities.
The first confirmed cases of CA-MRSA were identified from patients in Australia,
who developed infections despite lacking exposure to healthcare facilities or other risk
factors (Udo, Pearman, & Grubb, 1993). Soon after the outbreak in Australia, several
children in the United States died from MRSA infections that were later identified as CAMRSA ("Centers for Disease Control and Prevention. Four pediatric deaths from
community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North
Dakota, 1997-1999," 1999). Infections caused by CA-MRSA strains continued to become
more common, and today they account for the majority of MRSA infections. A recent
study found that community-onset infections accounted for 90% of MRSA infections in
San Francisco, CA (Liu et al., 2008). Another more recent study looked at the
phenotypes of MRSA infections observed in U.S. hospitals between 2005 to 2008, and
found that the proportion was 55% HA-MRSA, and 45% CA-MRSA, which remained
constant throughout the three year study (Klein, Sun, Smith, & Laxminarayan, 2013).
There are several fundamental differences between strains of CA-MRSA and HAMRSA, including the genetic makeup, associated risk factors, and prevalence. The main
genetic differences between HA-MRSA and CA-MRSA concern the type of staphylococcal
chromosomal cassette mec (SCCmec) incorporated into the genome. HA-MRSA strains
carry the mecA gene on the larger SCCmec types I, II, or III (David & Daum, 2010). HA9

MRSA strains carrying these SCCmec types are often resistant to other classes of
antibiotics in addition to the penicillins, cephalosporins and carbapenems. Additionally,
HA-MRSA strains rarely carry the PVL gene (LaPlante, Rybak, Amjad, & Kaatz, 2007). The
most common strains of HA-MRSA are USA100, USA800 and USA500 (Stefani et al.,
2012).
In contrast, CA-MRSA strains carry the mecA gene on the smaller SCCmec type IV
or V, which are less likely to encode multidrug resistance, a key difference between CAMRSA and HA-MRSA (Ma et al., 2002). Additionally, many strains of CA-MRSA carry the
PVL gene, which may enhance the virulence (LaPlante et al., 2007). The most commonly
identified strains of CA-MRSA are USA300 and USA 400 (Stefani et al., 2012).
The risk factors associated with colonization or infection with HA-MRSA or CAMRSA are quite different. The main risk factors associated with developing a HA-MRSA
infection are exposure to healthcare facilities and suffering from a number of health
problems (David & Daum, 2010). Additionally, older individuals are more likely to be
hospitalized from HA-MRSA phenotypes (Klein et al., 2013). The most common types of
HA-MRSA infections are pneumonia, bacteremia and invasive infection (Naimi et al.,
2003). On the other hand, CA-MRSA infections usually appear in healthy people with no
recent healthcare exposure (Herold et al., 1998). Additionally, CA-MRSA strains mainly
cause skin and soft-tissue infections, seem to be more virulent and are more easily
transmitted (DeLeo, Otto, Kreiswirth, & Chambers, 2010; Naimi et al., 2003). Several
populations have been found to have a higher risk of becoming infected with CA-MRSA
including prisoners (Maree et al., 2010), military personnel (Ellis, Hospenthal, Dooley,
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Gray, & Murray, 2004), children in day care centers (Miller et al., 2011), and men who
have sex with men (Diep, Chambers, et al., 2008). It is necessary to note that strains of
CA-MRSA have become endemic in healthcare facilities, in addition to being present in
the community (Maree, Daum, Boyle-Vavra, Matayoshi, & Miller, 2007).
Recently, attention has been given to the emergence of livestock-associated
MRSA (LA-MRSA). S. aureus has the ability to infect many types of livestock including
cows, pigs and chicken (Fitzgerald, 2012). This was not a serious concern until a recent
report found MRSA isolates in livestock may have the potential to infect humans (Cuny
et al., 2010). While LA-MRSA has not been identified as a major source of infections in
humans, it is being studied because of the potential impact it could have.
Impact of MRSA
S. aureus is part of the natural flora in humans. It is commonly found on the skin,
mucous membranes, axillae, vagina, pharynx and most frequently the nasal passage
(Lowy, 1998; Noble, Valkenburg, & Wolters, 1967). Research has shown that about 25%
to 30% of people are asymptomatically colonized with S. aureus and may be colonized
for long periods of time (Gorwitz et al., 2008; Graham, Lin, & Larson, 2006; Kluytmans,
van Belkum, & Verbrugh, 1997). However, of those people colonized with S. aureus, only
about 0.8% to 1.5% had antimicrobial resistant strains.
People who become colonized with S. aureus often have no clinical symptoms or
adverse health effects. Occasionally, under the right conditions, people who are
exposed to S. aureus may develop an infection. In fact, S. aureus is the leading cause of
infections across the globe (Diekema et al., 2001). Individuals colonized by S. aureus
11

have an increased risk of developing infections (von Eiff, Becker, Machka, Stammer, &
Peters, 2001). The most common types of S. aureus infections include bloodstream,
skin, soft tissue, bone, joint, and respiratory (Diekema et al., 2001). S. aureus can also
cause several other types of adverse health effects, ranging from boils, cellulitis, wound
infections, scalded skin syndrome, bacteremia, endocarditis, wound infections, to the
less frequent pneumonia or toxic shock syndrome (Mahon & Manuselis, 1995).
Additionally, S. aureus can produce an enterotoxin that can cause gastroenteritis if
ingested (Lowy, 1998).
S. aureus has become an enormous problem in healthcare settings, where it is a
leading cause of healthcare associated infections (HAIs). HAIs are infections that
patients acquire while being treated for other conditions, and are thereby potentially
preventable. The Centers for Disease Control and Prevention (CDC) has estimated that
for every 20 people hospitalized in the U.S., one will develop an HAI (CDC, 2013). The
most common types of HAIs include central line-associated bloodstream infections,
ventilator-associated pneumonia, catheter-associated urinary tract infections and
surgical site infections (Yokoe et al., 2008).
S. aureus infections were the most common cause of HAIs reported to the
National Healthcare Safety Network (NHSN) in 2009-2010 (Sievert et al., 2013). This was
an increase from 2006-2007 when they were the second most common cause (Hidron et
al., 2008). However, only about 43-65% of the reported S. aureus HAIs were caused by
methicillin-resistant strains, depending on the type of infection (Hidron et al., 2008;
Sievert et al., 2013). Studies have also found that S. aureus HAIs were the most common
12

cause of surgical site infections and ventilator associated pneumonia (Hidron et al.,
2008; Sievert et al., 2013)..
MRSA infections have a substantial impact on the United States population. In
addition to HAIs, it was estimated that, in 2005, S. aureus infections caused about
478,000 hospitalizations, of which more than half (278,000) were related to MRSA
(Klein, Smith, & Laxminarayan, 2007). In 2009, the estimated number of hospitalizations
caused by S. aureus increased to 697,248, of which 463,017 hospitalizations were MRSA
strains (Klein et al., 2013). Additionally, there are an estimated 94,360 invasive MRSA
infections each year that result in about 18,650 deaths (Klevens et al., 2007). Up to 86%
of invasive MRSA infections are HAIs, and potentially preventable.
The high percentage of S. aureus infections that are caused by MRSA strains is an
important public health concern. MRSA infections are harder to treat and often have
worse outcomes. MRSA infections are associated with increased morbidity and
mortality when compared to methicillin susceptible strains of S. aureus (Cosgrove et al.,
2003; Shorr et al., 2006).
Infections caused by MRSA also have an enormous economic impact around the
globe. Annually, in the European Union, MRSA infections are estimated to cause one
million extra days of hospitalization costing an extra €380 million (ECDC/EMEA Joit
Techical Report - The bacterial challenge: time to react 2009). One U.S. study found that
on average, a patient infected with a MRSA infection cost $19,405 more to treat than a
patient infected with susceptible S. aureus and were more likely to die (Filice et al.,
2010). A breakdown of the extra costs associated with MRSA found that only 20% could
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be attributed to increased infection control measures, such as improved contact
precautions, antimicrobial therapy and laboratory measures (Goetghebeur, Landry, Han,
& Vicente, 2007).
MRSA in Long-Term Care Facilities
The aging of the “baby boomer” generation in the U.S. is changing the makeup of
the United States healthcare systems. The number of long-term care facilities (LTCF) is
increasing, while the number of acute-care facilities (ACF) is decreasing (Manzur &
Gudiol, 2009). This change is significant because the majority of MRSA related research
has been focused on ACF, especially intensive care units.
There are several key characteristics of LTCF that increase the prevalence of
MRSA infections. The population in LTCF is comprised of older individuals who often
suffer from multiple health problems and have weakened immune systems (Richards,
2002). This makes them more susceptible to MRSA infections. Moreover, LTCF patients
often suffer from conditions that impact their sanitary habits, which may increase the
risk of acquiring infections. Additionally, LTCF serve as the patient’s residence and the
patients are involved in group activities throughout the facility, such as physical therapy,
meals, and social activities. This increases their exposure to other potentially infected
individuals and contaminated surfaces (Smith et al., 2008). Research has demonstrated
that the length of stay and multiple bed rooms are risk factors of MRSA transmission in
LTCF (Wendt, Svoboda, Schmidt, Bock-Hensley, & von Baum, 2005).
Treatment of MRSA Infections
Currently, the number of effective antimicrobials used to treat MRSA infections
14

is dwindling. Treatment options can vary depending on the type of infection and other
patient factors. Overall, the standard antimicrobial used to treat MRSA infections is
vancomycin (Gould et al., 2012; Kumar & Chopra, 2013). Nevertheless, strains of
vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA)
have emerged (Hiramatsu et al., 1997). Due to this fact, the Infectious Disease Society of
America (IDSA) recommends the use of other antimicrobials in situations where
vancomycin may not be successful. These other antimicrobials include daptomycin,
linezolid, clindamycin, telavancin, trimethoprim/sulfamethoxazole, and tetracycline,
which can be used solo or in combinations depending on the type of infection, patient
history, and other factors (Liu et al., 2011). Researchers are also working to develop new
antimicrobials in hopes of keeping viable treatment options in the future. The IDSA has
set the goal of developing 10 new antimicrobial drugs for multi-drug resistant organisms
by 2020 ("The 10 x '20 Initiative: pursuing a global commitment to develop 10 new
antibacterial drugs by 2020," 2010).
Routes of Transmission
Preventing the transmission of MRSA in healthcare facilities is a prominent public
health issue that could save thousands of lives. Overall, there are four main routes of
transmission of MRSA in healthcare facilities. They are direct contact with infected or
colonized individuals, indirect contact through contaminated hands of healthcare
workers, contaminated air and contaminated environmental surfaces or equipment
(Otter et al., 2011).
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Direct contact transmission occurs when a person is exposed to MRSA by
touching or coming into contact with an infected or colonized patient. This type of
transmission could occur when susceptible patients are roomed with infected or
colonized patients, but due to isolation and the use of contact precautions, this route is
not seen as a major contributor to transmission.
The role of contaminated healthcare worker’s hands is extremely important in
the transmission of MRSA (Ludlam et al., 2010). The hands of healthcare workers can
become directly contaminated while working with infected or colonized patients or
indirectly by touching contaminated surfaces or equipment. If their hands are not
decontaminated, they can spread MRSA to susceptible patients, who may then develop
a new healthcare acquired infection. Additionally, contaminated hands can be a source
of recontamination for environmental surfaces in other locations.
Contaminated air has also been implicated in the transmission of MRSA. This
most often occurs when the MRSA infection affects the respiratory system (Sherertz et
al., 1996). Air conditioning ducts have also been implicated (Wagenvoort, Davies,
Westermann, Werink, & Toenbreker, 1993). Direct airborne transmission is not seen as
a major contributor to new infections, but it has been shown to contribute to the
contamination of environmental surfaces, which are a more effective route of
transmission (Hardy, Oppenheim, Gossain, Gao, & Hawkey, 2006; Wilson et al., 2007).
Environmental surfaces contaminated with MRSA seem to be central for
transmission in healthcare facilities. Surfaces can become contaminated through
multiple paths: directly from bacteria shed by infected or colonized patients; indirectly
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from contaminated hands of healthcare workers; and indirectly from airborne particles
from patients or air ducts. Once these surfaces become contaminated with MRSA, they
remain contaminated until the surfaces are cleaned or the MRSA dies, which could be
up to a year (Kramer et al., 2006; Wagenvoort, Gelissen, & Timpert, 1997). This
reinforces the importance of environmental cleaning programs.
Infection prevention programs have been developed to address each of these
routes of transmission. Hand hygiene is the most powerful tool to reduce the
contamination of healthcare workers hands. Active surveillance can be used to identify
patients infected and colonized with MRSA. Once the patients are identified, healthcare
workers can use the correct contact precautions such as gloves, gowns and masks when
needed. Another tool is environmental cleaning. This project focused on the role of
contaminated surfaces and equipment in the transmission of MRSA because the link
between contaminated surfaces and the development of MRSA infections remains
unclear and requires more research.
Environmental Decontamination
The basic understanding and approach for disinfecting patient-care items and
equipment were developed over 40 years ago (Rutala & Weber, 2011). This approach
uses three classifications for patient-care items and equipment. First are critical items
that have a high risk of causing infections if contaminated. These are items inserted into
sterile body sites and must be sterilized before use. Semi-critical items are used in
contact with mucous membranes or non-intact skin and must undergo high levels of
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disinfection. The last classification is non-critical items, which are items that may
contact the intact skin and require low-level disinfection.
Environmental surfaces are considered non-critical items and, therefore, require
low-level disinfection on a daily basis. A recent report by the CDC has outlined the
guidelines for disinfection and sterilization in healthcare facilities (Rutala et al., 2008).
This document emphasizes that while MRSA has developed resistance to several types
of antibiotics, it can easily be eradicated through proper cleaning with detergents and
disinfectants. They point out that cleaning solutions must be used at the correct
concentrations, be applied to all surfaces, and remain in contact with the surfaces for an
adequate time to kill the bacteria. The contact time for most cleaners is at least 10
minutes (Rutala et al., 2008). Nevertheless, these steps are not always followed,
possibly leading to the persistence of viable MRSA on surfaces.
MRSA on Environmental Surfaces
Environmental surfaces can become contaminated with MRSA when bacteria are
shed into the environment by infected or colonized people. This can occur during events
such as sneezing, coughing, talking, eating, or routine medical care. Past studies have
demonstrated that infected or colonized patients shed their specific strain of MRSA into
the surrounding area, which results in high rates of contamination on surfaces and
objects in proximity to the patient (Boyce et al., 1997; French et al., 2004; Sexton et al.,
2006). Boyce, et al., (1997) observed more than 50% of floor samples, bed linen
samples, and patient gown samples were positive for MRSA. Additionally, they found
85% of patients with MRSA infected wounds or urine had environmental MRSA
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contamination compared to only 36% of patients with MRSA infection in the sputum,
blood or conjunctivae. Contamination also increased with the number of culture
positive body sites. Infected patients rooms were also found to have 32% of sampled
surfaces contaminated compared to just 20% of surfaces in colonized patient rooms.
Once these bacteria are shed onto environmental surfaces, they remain there
until they die or are removed by cleaning. If they are not cleaned or eradicated research
has shown that MRSA may remain viable on environmental surfaces for long periods of
time up to 318 days (Kramer et al., 2006; Wagenvoort et al., 1997; Wagenvoort,
Sluijsmans, & Penders, 2000). There are a number of factors that impact the persistence
of MRSA on environmental surfaces. Recent studies indicated lower temperatures,
lower levels of humidity and the presence of organic material, such as bovine serum
albumin (used to mimic organic material) all increased the length of survival
(Coughenour, Stevens, & Stetzenbach, 2011; Noyce, Michels, & Keevil, 2006).
Additionally, the type of materials surfaces are composed of impacts survival, with
plastic and vinyl increasing survival times compared to wood (Coughenour et al., 2011).
Incorporating copper into surfaces may also decrease survival times (Noyce et al., 2006).
When comparing MRSA strains to non-resistant strains, survival times are similar (Neely
& Maley, 2000), but MRSA strains that were more likely to cause an outbreak were
shown to survive longer than normal MRSA strains (Wagenvoort et al., 2000).
The role of contaminated environmental surfaces in causing infections is still
being debated. It is understood that the concentration of MRSA on environmental
surfaces has been measured at levels high enough for transmission (Otter et al., 2011).
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For example, a study found the average concentration of MRSA on surfaces to be
between 1 Colony Forming Unit (CFU)/cm2 to 100 CFU/cm2 (Rutala, Katz, Sherertz, &
Sarubbi, 1983), which is higher than the infectious dose of less than 15 S. aureus cells,
shown to cause infection in experimental lesions (Foster & Hutt, 1960). Additionally,
surfaces contaminated with MRSA were implicated in causing new infections during a
MRSA outbreak in a London surgical ward (Jeanes, Rao, Osman, & Merrick, 2005).
Furthermore, a study was able to match strain types of environmental samples and
patients, implying 3 of 26 patients were infected from the environment (Hardy et al.,
2006).
Many studies have been conducted to evaluate the presence of MRSA on a
variety of surfaces, but the results have varied widely. Hardy et al., (2006) found MRSA
present in 21.8% of samples at a hospital, with the area underneath the bed having the
highest level of contamination. Boyce et al., (1997) had similar results when they
examined surfaces in a hospital and found that 27% of environmental samples were
MRSA positive, with the floor being the most contaminated. Sexton et al., (2006)
examined a 720 bed hospital with two intensive care units and found much higher rates
of contamination, with 56.3% of surface samples contaminated with MRSA. Door
handles have also been found to be contaminated in 19% of MRSA patient rooms and
8.7% of all patient rooms (Oie, Hosokawa, & Kamiya, 2002).
Overall, the healthcare surfaces that are touched frequently and are in proximity
of patients have been shown to have a higher frequency of contamination with MRSA
(Boyce et al., 1997; Hayden, Blom, Lyle, Moore, & Weinstein, 2008; Huslage, Rutala,
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Sickbert-Bennett, & Weber, 2010). These surfaces are called “high-touch surfaces” and
include the bed rails, the bed surface, and the supply cart. Recently, environmental
cleaning programs have been focusing cleaning efforts on these “high-touch” areas in
the hope of reducing transmission, but more research is needed to evaluate the
effectiveness. A recent study found that increasing the cleaning of “high touch” surface
to twice daily reduced MRSA surface contamination from 14.6% to 9.1%. Additionally, it
found that contamination on doctors and nurses hands by MRSA was reduced during
the intervention (Wilson et al., 2011).
Environmental sampling has also been used to evaluate the presence of MRSA
after several other types of cleaning interventions. One study evaluated the effect of
adding an additional cleaner into a UK hospital and found that microbial contamination
was lowered by 32.5%, which reduced new MRSA infections by 26% (Dancer, White,
Lamb, Girvan, & Robertson, 2009). Disinfection wipes were found to reduce MRSA
contamination on bed rails from 4.4 CFU/cm2 to 0.4 CFU/cm2 (Cheng, Boost, & Chung,
2011). A study of 10 intensive care units during enhanced cleaning intervention found
that new MRSA infections were lowered from 3% to 1.5% (Datta, Platt, Yokoe, & Huang,
2011). They also found that patients who were placed in rooms previously occupied by a
MRSA patient had an increased risk of developing an infection in the control group but
not the intervention group. Another study found that 16% of sites contained MRSA after
bleach and steam cleaning (Jeanes et al., 2005).
A newer type of disinfectant that has been shown to be highly effective in
removing MRSA from the environment is hydrogen peroxide vapor (HPV). French et al.,
21

(2004) compared MRSA contamination following normal terminal cleaning procedures
with the use of HPV. They found that before cleaning, 74% of swabs were positive for
MRSA. After terminal cleaning, this was lowered to 66% of swabs being positive
compared to only 1.2% positive swabs obtained after the use of HPV. Another study
also found HPV was effective in removing MRSA from environmental surfaces in an
intensive care unit, but once MRSA infected patients were readmitted the room quickly
became recontaminated (Hardy et al., 2007). These two studies show HPV may be more
effective than normal terminal cleaning, but more research is needed to determine the
feasibility in multiple types of facilities.
MRSA contamination is not limited to rooms of infected patients. MRSA was
identified in 43% of beds used by uninfected patients (Boyce et al., 1997). This
contamination of uninfected rooms could be due to bacteria shed by previous
occupants (French et al., 2004; Hardy et al., 2006), or recontamination from healthcare
workers, visitors, or other patients (Otter et al., 2011). Healthcare workers are the most
likely source of recontamination. A recent study found that compliance by healthcare
workers to hand hygiene varies widely, with an overall average of only 40% (Boyce &
Pittet, 2002). Furthermore, a study found that 66% of healthcare workers who work
directly with MRSA patients obtain the patient’s strain on their apron or gloves, and
even if the healthcare worker did not have contact with the patient, 40% still became
contaminated with MRSA (Boyce et al., 1997).
Cleaning of environmental surfaces and equipment is an essential tool in
infection prevention, but it is often overlooked because surface contamination is not
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thought to be a leading contributor to the transmission MRSA. Nevertheless, research
has shown the hospital environment is not adequately cleaned. A recent study
examined the thoroughness of terminal cleaning at 23 acute care hospitals and found
that only 49% of surfaces were adequately cleaned (Carling, Parry, & Von Beheren,
2008). The study also identified the areas least likely to be cleaned were the toilet
handholds, bedpans, light switches and door knobs, and most likely to be cleaned were
the sinks, toilet seats and tray tables. This is particularly concerning because MRSA has
been identified on hospital surfaces where it may directly or indirectly be transmitted to
susceptible patients resulting in new infections.
This is a concern because MRSA has been identified on hospital surfaces where it
may directly or indirectly be transmitted to susceptible patients, resulting in new
infections. The majority of previous studies examining the presence of MRSA on
surfaces have been conducted in acute care hospitals. With the growing number of longterm care facilities, it is vital to identify the differences in surface contamination
between these locations. Additionally, to date no studies have evaluated the presence
of MRSA on environmental surfaces in healthcare facilities in southern Nevada and the
antimicrobial susceptibility profiles of environmental Staphylococcus aureus isolates
present in southern Nevada have not been adequately examined.
Objectives
The role of environmental surface contamination in the transmission of MRSA is
still unclear. It is known that patients infected or colonized with MRSA shed bacteria
into the environment. Additionally, it has been found that MRSA can survive for long
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periods of time on hospital surfaces and in dust. These bacteria that are present on
hospital surfaces may be transmitted to new patients resulting in new colonization or
infections. Few studies have examined the effectiveness of environmental cleaning in
removing MRSA from environmental surfaces. In addition, the prevalence of MRSA in
healthcare facilities in southern Nevada is unknown.
The objectives of this study are to:
(1) Determine the prevalence of MRSA from colonized or infected patient’s rooms
on five different environmental surfaces pre-and post-cleaning at an acute care
hospital and a long-term care facility.
(2) Evaluate the effectiveness of the environmental cleaning in removing MRSA
contamination from five high touch surfaces at each facility.
(3) Compare the results from the acute care hospital and the long-term care facility.
(4) Identify the antimicrobial susceptibility profiles of MRSA isolates present in
southern Nevada.
Research Questions and Hypotheses
1. Is MRSA present on environmental surfaces in infected and colonized patient
rooms pre-cleaning?
2. Do environmental cleaning programs effectively remove MRSA bacteria from
environmental surfaces in infected or colonized patient rooms?
Hypothesis 1: The prevalence of MRSA will be higher in the pre-cleaning samples than
the post-cleaning samples at the Acute Care Hospital.
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Ho1: There is no difference between the prevalence of MRSA in the pre-cleaning
and post-cleaning samples collected at the Acute Care Hospital.
HA1: There is a difference between the prevalence of MRSA in the pre-cleaning
and post-cleaning samples collected at the Acute Care Hospital.
Hypothesis 2: The prevalence of MRSA in the pre-cleaning samples will be higher than
the post-cleaning samples at the long-term care facility.
Ho2: There is no difference between the prevalence of MRSA in the pre-cleaning
and post-cleaning samples collected at the long-term care facility.
HA2: There is a difference between the prevalence of MRSA in the pre-cleaning
and post-cleaning samples collected at the long-term care facility.
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CHAPTER 3
MATERIALS AND METHODS
Experimental Design
This study was conducted at an acute-care hospital (ACH) and a long-term care
facility (LTCF) located in southern Nevada. Following the discharge of patients infected
or colonized with MRSA, environmental surface samples were collected in patient
rooms. In each patient room, 5 pre-terminal cleaning samples and 5 matching postterminal cleaning samples were collected from five different environmental surfaces.
Fifty swab samples were collected from five patient rooms at the ACH and the LTCF, and
an additional 20 sponge samples were collected from two patient rooms at the LTCF, for
a total of 120 samples. Following collection, the samples were analyzed for the presence
of S. aureus and MRSA by culture analysis using two types of selective media. Any
positive MRSA isolates underwent confirmatory analyses with real-time polymerase
chain reaction (PCR) analysis for the mecA gene. To characterize each MRSA isolate, the
antibiotic susceptibility profiles were identified using the VITEK® 2 Compact
(bioMérieux, Durham, NC).
Quality Control Organisms and Culture Media
Four bacterial reference strains were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). These included Staphylococcus aureus ATCC 25923, a
methicillin-sensitive and coagulase positive strain, Staphylococcus aureus ATCC 43300
(MRSA) a methicillin-resistant strain, Enterococcus faecalis ATCC 29212, used for quality
control of commercially prepared media and antimicrobial susceptibility testing, and
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Staphylococcus aureus ATCC 29213, used as a standard for antimicrobial susceptibility
testing. The media used for this study was obtained from BD Diagnostics (Sparks, MD)
and included BBL™ CHROMagar™ Staph aureus, BBL™ CHROMagar™ MRSA, Difco™
tryptic soy agar, Trypticase™ soy agar with 5% sheep blood, and Trypticase™ soy broth
with 6.5% sodium chloride (enrichment broth).
Sample Collection
Collection techniques and laboratory methods were adapted from previous work
(Buttner et al., 2010; Ezeanolue, 2008). Environmental surface swabs were collected by
trained hospital staff from each healthcare facility following standard surface sampling
protocols (French et al., 2004). Following the discharge of patients infected or colonized
with MRSA, 10 environmental surface samples (5 pre-cleaning and 5 post-cleaning) were
collected in the room from five different environmental surfaces pre-terminal cleaning
and then repeated at least one hour following post-terminal cleaning. The pre-cleaning
and post-cleaning samples were collected from the same five locations in each patient
room. The sampling locations included the floor, bed rail, TV remote control or call bell,
bathroom doorknob, and bedside table (Figure 1). These locations were chosen because
they are high-touch areas or were in proximity to the patients. The hospital staff
identified an approximate 2” by 2” surface area on each surface to sample. The exact
sampling locations were chosen by hospital staff to be as close to the patient bed as
possible for the floor and bedside table and the area that was most likely to be touched
by the hands of the patients for the bed rail, call bell, TV remote and bathroom
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doorknob. Because all of the surfaces where different shapes and sizes, the area
sampled was an approximation.
Two different sampling techniques were used. One hundred samples, fifty from each
facility, were collected using a moistened sterile swab (BBL CultureSwab; BD
Diagnostics) that was used to swab an approximate 2 inch by 2 inch surface area, in two
directions, at each location and placed into a tube of sterile liquid Stuart transport
medium (BD Diagnostics). An additional 20 samples were collected from the LTCF using
sterile all-purpose sponges (Tyco Healthcare Group; Mansfield, MA) moistened with
ultrapure water. The sponges were used as an alternative sampling method because of
low positive results obtained using the swabs. The all-purpose sponge was used to wipe
a 2 inch by 2 inch surface area, in two directions, and placed into a sterile tube of 10ml
ultrapure water. All samples were refrigerated overnight at the healthcare facility,
transported to the Emerging Diseases Laboratory, (University of Nevada, Las Vegas) the
following day, and processed within 24 hours of collection.
Sample Processing
Sample analysis procedures were adapted from previous studies (Buttner et al.,
2010; Ezeanolue, 2008). All swabs were streaked for isolation onto CHROMagar™ Staph
aureus and CHROMagar™ MRSA (BD Diagnostics) and incubated in ambient atmosphere
at 35°C for 24 hours. The swabs were then placed in enrichment broth (BBL Trypticase
Soy Broth with 6.5% Sodium Chloride, BD Diagnostics), vortexed for 10 seconds and
shaken at 130 rpm for 24 hours in a 35°C environmental shaker incubator. The
incubation in enrichment broth was conducted to enhance the survival of stressed or
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damaged bacteria on environmental surfaces and increase the ability to detect MRSA.
Following incubation, using a sterile loop, 10μl of the enrichment broth was subcultured
onto CHROMagar™ Staph aureus and CHROMagar™ MRSA and streaked for isolation,
followed by incubation in ambient atmosphere at 35°C for 24 hours.

Figure 1. Environmental Sampling Locations. The five environmental sampling locations
included the floor, bedside table, bed rail, call bell or television remote (not shown) and
bathroom doorknob.

All sponge samples were vortexed in 10ml of ultrapure water for one minute and
100μl was spread plated onto CHROMagar™ Staph aureus and CHROMagar™ MRSA (BD
Diagnostics) and incubated in ambient atmosphere at 35°C for 24 hours. Additionally,
100μl of the votexed solution was dispensed into enrichment broth (BBL Trypticase Soy
Broth with 6.5% Sodium Chloride, BD Diagnostics), vortexed for 10 seconds and shaken
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at 130 rpm for 24 hours in a 35°C environmental shaker incubator. Following
incubation, using a sterile loop, 10μl of the enrichment broth was subcultured onto
CHROMagar™ Staph aureus and CHROMagar™ MRSA and streaked for isolation,
followed by incubation in ambient atmosphere at 35°C for 24 hours.
All agar plates were inspected for positive colonies. Any CHROMagar™ MRSA plates
without typical MRSA colonies after 24 hours of incubation were incubated for an
additional 24 hours. All CHROMagar™ Staph aureus plates without typical
staphylococcal colonies after 24 hours of incubation were discarded. Positive results
were determined using the manufacturer’s instructions. Mauve to orange/mauve
colonies that grew on CHROMagar™ Staph aureus medium were identified as S. aureus
isolates. Smooth, moderately sized mauve colonies that grew on CHROMagar™ MRSA
medium at 24 hours were recorded as MRSA. Any mauve colonies that first appeared at
48 hours were confirmed with further testing. All presumptive MRSA isolates were then
stored at -70°C for use in additional testing.
DNA Extraction and Purification
Several colonies from each MRSA positive sample were suspended in 500μl of 0.01
M potassium phosphate buffer with 0.05% Tween 20, pH 7.0 (Sigma-Aldrich Co., St.
Louis, MO). Additionally, 500μl of the liquid Stuart transport medium was collected from
the post-cleaning samples corresponding to each of the MRSA positive pre-cleaning
samples to test for the presence of DNA from non-viable MRSA. The DNA was extracted
from the 500μl samples using an UltraClean Soil DNA Isolation Kit (MO BIO, Carlsbad,
CA) following the manufacturer’s protocol. The DNA was resuspended in 50 μl of Tris30

EDTA buffer pH 8.0 (Sigma-Aldrich, St. Louis, MO), diluted 10-and 100-fold, and stored at
–70°C for future use.
Real-Time Polymerase Chain Reaction
A real-time PCR assay was conducted for all of the culture identified MRSA
isolates and the corresponding culture negative post-cleaning samples to detect the
mecA gene (P. Francois et al., 2003). The procedure used was adapted from previous
studies (Buttner et al., 2010; Ezeanolue, 2008). The analysis was performed with the
7900 HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA) using the
TaqMan® technology (Applied Biosystems). The probes and primers were the same as
used in previous studies (P. Francois et al., 2003). The sequence of the forward primer
was 5′-CATTGATCGCAACGTTCAATTT-3′, the reverse primer was 5′TGGTCTTTCTGCATTCCTGGA-3′ and the probe was 5′-6FAM-TGGAAGTTAGATTGGGAT
CATAGCGTCAT-TAMRA 3′. All DNA samples were analyzed at three different
concentrations (undiluted, 10-1 and 10-2) to avoid false negative results. Each PCR
reaction contained a total volume of 25μl, that included nuclease free water (Promega,
Madison, WI), 1X of TaqMan® Universal PCR Master Mix (Applied Biosystems), 0.1μM of
the mecA forward primer (Eurofins MWG Operon, Huntsville, AL), 0.1μM of the mecA
reverse primer (Eurofins MWG Operon), 0.075μM of the mecA probe (ABI) and 5μl of
template DNA. The instrument was operated in standard mode with the following
parameters: 2 min at 50°C, 10 min at 95°C, and 40 cycles of 15 sec at 95°C followed by 1
min at 60°C. All samples were amplified in duplicate and a non-template control
(nuclease free water) and a positive control (ATCC 43300, a MRSA strain) were included
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in each analysis. A TaqMan® exogenous internal positive control using a VICTM probe
(Applied Biosystems) was also used to test for inhibition in selected samples. Following
completion of amplification, the results from each run were analyzed using the AB
software Sequence Detection System (SDS) version 2.3. Amplification was reported by
the mean CT value of two replicates. The definition of a CT value is the PCR cycle number
when a detectable amplification product crosses the threshold.
Antimicrobial Susceptibility Testing
All positive MRSA isolates were subjected to antibiotic susceptibility testing (AST)
using the gram positive S. aureus specific AST-GP71 card for the VITEK® 2 Compact
(bioMérieux, Durham, NC) following the manufacturer’s protocol. The concentrations of
the antimicrobial agents analyzed are shown in Table 1. Briefly, the MRSA isolates and
quality control (QC) organisms (E. faecalis ATCC 29212 and S. aureus ATCC 29213) were
subcultured onto Trypticase® Soy Agar with 5% Sheep Blood (TSAB, BD Diagnostics) in a
Bio Safety Cabinet and incubated for 18-24 hours in ambient atmosphere at 35°C.
Several colonies were picked using sterile cotton swabs and suspended into 3.0ml of
sterile 0.45% sodium chloride inhalation solution (Care Fusion, Yorba Linda, CA) until an
optical density of 0.5 – 0.63 McFarland standard was observed. Next 285μl of this
solution was resuspended into 3.0ml of sterile 0.45% sodium chloride solution to be
used for analysis. The MRSA and QC suspensions were loaded onto the AST-GP71 cards,
and then analyzed in the VITEK® 2 Compact. Results of the susceptibility profile were
stored electronically in the system and evaluated.
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Table 1. Antimicrobial Agents analyzed by the VITEK® 2 Compact AST-GP71 Card.
Antimicrobial Agent

Concentration(s) μg/ml

Benzylpenicillin

0.125, 0.25, 1

Beta-Lactamase

N/A*

Cefoxitin Screen

6

Ciprofloxacin

1, 2, 4

Clindamycin

0.5, 1, 2

Daptomycin

0.5, 1, 2, 4, 16

Erythromycin

0.25, 0.5, 2

Gentamicin

8, 16, 64

Inducible Clindamycin Resistance

CM 0.5, CM/E 0.25/0.5*

Levofloxacin

0.25, 2, 8

Linezolid

0.5, 1, 2

Minocycline

0.12, 0.5, 1

Moxifloxacin

0.25, 2, 8

Nitrofurantoin

16, 32, 64

Oxacillin

0.5, 1, 2

Quinupristin/ Dalfopristin

0.25, 0.5, 2

Rifampicin

0.25, 0.5, 2

Tetracycline

0.5, 1, 2

Tigecycline

0.25, 0.5, 1

Trimethoprim/ Sulfamethoxazole

2/38, 8/152, 16/304

Vancomycin

1, 2, 4, 8, 16

*N/A = not applicable; CM = Clindamycin; E = Erythromycin

Statistical Analysis
A total of 120 samples were collected in this study. The results were analyzed
to determine the prevalence of MRSA pre-cleaning and post-cleaning. A Wilcoxon
signed-rank test was performed to compare the prevalence of MRSA in pre-cleaning
versus post-cleaning results at each facility. This test was chosen because it is a nonparametric statistical test used to compare pre- and post-paired samples and is valid for
small sample sizes. The Wilcoxon signed-rank test, descriptive and inferential statistics
were calculated using SPSS version 19.0.
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CHAPTER 4
RESULTS
Environmental Sample Analysis
A total of 120 environmental surface samples were obtained from the two
healthcare facilities; 50 from the acute care hospital (ACH) and 70 from the long-term
care facility (LTCF). The detection limit for the 2” by 2” surface sampling area was
estimated to be 0.4 CFU/cm2. Culture analysis followed by confirmatory PCR analysis for
the mecA gene identified that 18 of the 120 samples (15%) contained viable MRSA.
Sixteen of the 18 MRSA positive samples were obtained 48 hours after direct inoculation
onto CHROMagarTM MRSA media. Two additional MRSA positive samples were obtained
after 24 hour incubation in enrichment broth followed by inoculation onto
CHROMagarTM MRSA media. Of these two samples, one was obtained 24 hours after
inoculation and one was obtained 48 hours after inoculation.
The distribution of the positive samples by collection time, facility and sampling
technique can be seen in Table 2. Of the 50 samples collected at the ACH, 3 samples
(6%) were MRSA positive compared to 15 samples (21%) of the 70 samples collected at
the LTCF. Of the total 18 MRSA positive samples, 16 samples (89%) were collected preterminal cleaning, and 2 samples (11%) were collected post-terminal cleaning. A
distribution of the total samples collected and the number and percent of MRSA
positive samples by location and collection time can be seen in Table 3. Overall, the call
bell had the highest percentage of MRSA positive samples followed by the floor and bed
rail and the bedside table had the lowest.
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Table 2. The collection time, facility and sampling method of the 18 MRSA culture positive
environmental samples
Pre-Terminal Cleaning
Post-Terminal Cleaning
Total Swab Samples

Samples
collected

MRSA
Positive

Samples
collected

MRSA Positive

Acute Care Hospital
Long-Term Care Facility

25
25

3 (12%)
9 (36%)

25
25

0 (0%)
2 (8%)

Total Sponge Samples
Long-Term Care Facility

10

4 (40%)

10

0 (0%)

Total Samples

60

16 (26.7%)

60

2 (3.3%)

Further analysis of the MRSA positive environmental samples showed that of the
12 rooms sampled, 7 rooms (58%) had a MRSA positive sample from at least one
location and 5 rooms (42%) did not have any MRSA positive samples. Additionally, 4
rooms (33%) had MRSA positive samples from more than one location. Analysis of the
sample collection time showed 6 rooms (50%) had pre-cleaning MRSA positive samples,
while only 1 room (8%) had post-cleaning positive samples.
A Wilcoxon signed-rank test was performed, using SPSS 19.0, to evaluate the
difference in MRSA prevalence in pre-cleaning compared to post-cleaning samples at
the ACH and LTCF. The results showed there was not a statistically significant difference
at the α = 0.05 level between the prevalence of MRSA positive pre-cleaning samples and
post-cleaning samples collected from the five different environmental surfaces at the
acute care hospital (Z= -1.732, p = 0.083), but there was a statistically significant
difference between the prevalence of MRSA positive pre-cleaning samples and post35

cleaning samples collected from the five different environmental surfaces at the longterm care facility (Z= -3.317, p = 0.001). The sample size for each surface was under 20
and therefore inadequate to statistically analyze the differences between surfaces.

Table 3. Number of total samples and MRSA culture positive samples by collection time and
location
Collection
Time

Pre-Terminal Cleaning

Post-Terminal Cleaning

Samples
collected

MRSA
Positive

Samples
collected

MRSA
Positive

Samples
collected

MRSA
Positive

Floor
Call Bell
Bathroom
doorknob

12
7

5 (42%)
4 (57%)

12
7

1 (8%)
1 (14%)

24
14

6 (25%)
5 (36%)

12

2 (17%)

12

0 (0%)

24

2 (8%)

Bed Rail
Bedside Table
TV Remote
Total

12
12
5
60

4 (33%)
0 (0%)
1 (20%)
16 (27%)

12
12
5
60

0 (0%)
0 (0%)
0 (0%)
2 (3%)

24
24
10
120

4 (17%)
0 (0%)
1 (10%)
18 (15%)

Surface

Total

PCR Results
The CT values for each of the 18 MRSA isolates can be seen in Table 4. Each
sample was analyzed at three concentrations (undiluted, 10-1 and 10-2), but the results
for the undiluted samples were negative due to inhibition of the PCR reaction. Selected
undiluted samples were tested with an internal positive control (IPC) to confirm
inhibition. The IPC CT value was 29.64 and all of the undiluted samples tested had IPC
values at least 1 CT value higher, indicating inhibition (see Appendix A for results).
Isolates were considered positive for the mecA gene if the corresponding CT value was
<40. Additional real-time PCR testing was conducted on the corresponding post36

cleaning environmental samples for each of the MRSA culture positive samples. All of
the samples had an undetermined CT value, indicating the mecA gene was not detected
in rooms post-cleaning (Appendix B).

Table 4. Real time PCR analysis of environmental samples for the presence of the
mecA gene at two concentrations.

Mean CT value
DNA Dilution
Facility
ACH
ACH
ACH
LTCF
LTCF
LTCF

Sample ID
4B
4C
5A
6A
6B
6C

LTCF
LTCF
LTCF
LTCF
LTCF
LTCF

6D
6F
6H
7A
7B
7C

LTCF
LTCF
LTCF
LTCF
LTCF
LTCF

7D
8C
11A
11B
11C
12A

Sample Location
Bed Rail
TV Remote
Floor
Floor
Bed Rail
Call Bell
Bathroom
doorknob
Floor
Call Bell
Floor
Bed Rail
Call Bell
Bathroom
doorknob
Call Bell
Floor
Bed Rail
Call Bell
Floor

Pre or Postcleaning
Pre
Pre
Pre
Pre
Pre
Pre

10-1
22.2
21.6
22.4
29.0
26.3
28.6

10-2
25.2
25.3
25.4
31.9
30.0
31.6

Pre
Post
Post
Pre
Pre
Pre

28.3
25.7
26.5
27.1
32.9
24.5

31.8
29.7
30.2
30.6
36.5
28.2

Pre
Pre
Pre
Pre
Pre
Pre

25.1
25.7
20.1
22.0
25.7
31.4

28.7
29.6
23.1
24.9
26.8
34.9

Antibiotic Susceptibility
The antimicrobial susceptibility profile was obtained with the VITEK® 2 Compact
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for each of the 18 MRSA isolates (Appendix C). Overall, there were 16 different
antimicrobial susceptibility profiles from the 18 isolates. The antimicrobial susceptibility
profiles for the pre- and post-terminal cleaning MRSA isolates collected from the same
location were found to have several differences when compared (Table 5).

Table 5. Comparison of the antimicrobial susceptibility profiles of the pre-cleaning versus
post-cleaning samples from the same location in the same patient room.
Collection time
Pre-Cleaning Post-Cleaning
Pre-Cleaning Post-Cleaning
Sample
6A
6F
6B
6H
Location
Floor
Floor
Call Bell
Call Bell
Antimicrobial Agent
Beta-Lactamase

+

+

+

+

Cefoxitin Screen
Benzylpenicillin
Oxacillin
Gentamicin
Ciprofloxacin
Levofloxacin
Moxifloxacin

+
R
R
S
R
R
I

+
R
R
S
R
R
R

+
R
R
S
R
R
I

+
R
R
S
R
R
I

Inducible Clindamycin Resistance
Erythromycin
Clindamycin
Quinupristin/Dalfopristin
Linezolid
Daptomycin

R
R
S
S
S

+
R
R
S
S
S

S
S
S
S
S

+
R
R
S
S
S

Vancomycin
Minocycline
Tetracycline
Tigecycline
Nitrofurantoin
Rifampicin

S
S
S
S
S
S

S
S
S
S
S
S

S
S
S
S
S
S

S
S
S
S
S
S

Trimethoprim/Sulfamethoxazole

R

S

R

R

S = susceptible; R = resistant; I = intermediate susceptibility; - represents negative result; +
represents positive result
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The percentage of total isolates susceptible to each of the antimicrobial agents
tested is shown in Figure 2. All of the isolates were susceptible to daptomycin, linezolid,
minocycline, quinupristin/dalfopristin, rifampicin, and tigecycline. Additionally, all of the
isolates were resistant or intermediate to benzylpenicillin, ciprofloxacin, levofloxacin,
moxifloxacin and oxacillin. All isolates had positive results for Beta-lactamase and
cefoxitin screen. Only one isolate was not susceptible to vancomycin. The susceptibility

Antimicrobial Agent

to the remaining antimicrobials varied among the isolates.

Vancomycin
Trimethoprim/Sulfamethoxazole
Tigecycline
Tetracycline
Rifampicin
Quinupristin/Dalfopristin
Oxacillin MIC
Nitrofurantoin
Moxifloxacin
Minocycline
Linezolid
Levofloxacin
Inducible Clindamycin Resistance
Gentamicin
Erythromycin
Daptomycin
Clindamycin
Ciprofloxacin
Cefoxitin Screen
Beta-Lactamase
Benzylpenicillin
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percent of susceptible isolates

Figure 2. The percentage of MRSA isolates susceptible to antimicrobial agents. The
antimicrobial susceptibility profiles of the 18 environmental MRSA isolates collected at
two healthcare facilities in southern Nevada. Isolates were analyzed by the VITEK® 2
Compact using the AST-GP71 card (bioMérieux, Durham, NC).
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CHAPTER 5
DISCUSSION
MRSA Prevalence
The main objective of this study was to determine the prevalence of MRSA from
colonized or infected patients’ rooms on five different environmental surfaces preterminal and post-terminal cleaning at two healthcare facilities. Overall, the percent of
total samples positive for MRSA collected at both facilities was 27% for pre-terminal
cleaning samples, 3% for post-terminal cleaning samples, and 15% for total samples
collected. Previous environmental sampling studies have had varying results, with the
percent of MRSA positive samples detected ranging from 10% (Rampling et al., 2001) to
61% (Chang et al., 2009). The results of this study are within that range, but are closer to
the lower prevalence results that have been seen.
Facility Differences
The results differed between the acute care hospital (ACH) and the long-term
care facility (LTCF). The prevalence of MRSA was found to be statistically significant
between the pre-cleaning and post-cleaning samples collected at the LTCF (p =0.001)
but not at the ACH (p = 0.083). The ACH had samples positive for MRSA in 12% of preterminal cleaning, 0% of post-terminal cleaning and 6% of total collected, which is
considerably lower than previous studies conducted in hospitals (Blythe, Keenlyside,
Dawson, & Galloway, 1998; Boyce et al., 1997; Chang et al., 2009; French et al., 2004;
Hardy et al., 2006; Rampling et al., 2001; Sexton et al., 2006; Wilson et al., 2011). In
contrast, the LTCF had 43% of pre-terminal cleaning, 6% of post-terminal cleaning and
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21% of total collected samples positive for MRSA. This is comparable with the previous
studies conducted in acute care hospitals, but to our knowledge no comparable studies
have been conducted in LTCF.
The percentage of MRSA-positive environmental samples has been shown to
have a high variability, which may be dependent on many factors. One key factor is the
status of the patient who occupied the room prior to sampling. Colonized patients have
been found to shed fewer bacteria than infected patients, and the amount shed by
infected patients can vary depending on the type of infection (Boyce et al., 1997). This
study did not differentiate between colonized and infected patients, and including both
may have resulted in a lower positivity rate. Additionally, no health information was
collected on the patients’ status.
Results can also vary depending on the sampling technique used (Galvin, Dolan,
Cahill, Daniels, & Humphreys, 2012). This study used a swab sampling technique
comparable to many previous studies (Blythe et al., 1998; Boyce et al., 1997; Chang et
al., 2009; Hardy et al., 2006; Rampling et al., 2001). One factor that may have impacted
the results was the use of swabs originally designed to be used as a nasal swab and not
a swab specifically designed for environmental surfaces. These swabs had a small
surface area and could only be used to sample approximately 2” by 2” on each surface.
In addition, each surface had a different total surface area and the proportion of total
surface area sampled differed for each surface.
Prevalence of MRSA Post-terminal Cleaning
The percent of MRSA positive post-terminal cleaning samples observed in this
41

study is lower than those observed in previous studies (Blythe et al., 1998; French et al.,
2004; Hardy et al., 2007; Wilson et al., 2011). This was expected if the rooms were
adequately cleaned. A study by French et al., (2004) observed a 66% MRSA positivity
rate of post-cleaning samples collected in a surgical ward with a detergent sanitizer used
for cleaning. Another study conducted in a surgical ward during an outbreak of MRSA
found only 16% of post-cleaning samples positive for MRSA, but they used bleach and
steam cleaning (Jeanes et al., 2005). The samples in this study were collected in a
different setting, an acute care hospital and a long-term care facility, that serve different
populations and may use different cleaning procedures, which may have resulted in
lower prevalence rates. Both of the facilities in this study use quaternary ammonium
disinfectants (Appendix D) approved by the Environmental Protection Agency (EPA) to
be effective against MRSA (EPA, 2009). Additionally, the low prevalence of MRSA
positive post-cleaning samples does not prove that the room was free from MRSA. The
relatively small sampling area of the swabs may not have been able to detect viable
MRSA present throughout the room.
Although cleaning was found to be effective, two viable MRSA isolates were
collected after terminal cleaning. Both of these isolates were identified from the same
patient room at the LTCF. There are two explanations for why these samples were
detected post-cleaning. The first is that the MRSA shed by the infected or colonized
patient was not removed or eradicated during the cleaning process. Environmental
cleaning has been shown to be ineffective if the cleaning solutions are not used at the
appropriate concentrations or not applied to all surfaces for the proper contact times
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(Rutala et al., 2008). The second possibility is that the room could have been
recontaminated after cleaning by the environmental cleaning staff or another
healthcare worker (Otter et al., 2011). Upon further analysis of the pre-cleaning and
post-cleaning samples that were collected from the same location in the same room, it
was found that the isolates had different antibiotic susceptibility profiles, suggesting
that the room may have been recontaminated (Table 4). Additional analyses, such as
strain typing, would be required to confirm this difference.
Surface Differences
This study also examined the prevalence of MRSA on six different surfaces (floor,
bedside table, bed rail, call bell, television remote, and bathroom doorknob). Each of
these surfaces is composed of different materials. The floors were vinyl, a surface on
which MRSA has been shown to have an increased survival time compared to wood and
metal (Coughenour et al., 2011). This may have contributed to 6 out of the 18 MRSA
positive samples being collected from the floor, which corroborates previous studies
that have also found the floor to have a high level of contamination (Blythe et al., 1998;
Boyce et al., 1997; Hardy et al., 2006).
Several of the other surfaces consisted of plastic, which has been shown to
increase MRSA survival time (Coughenour et al., 2011). The plastic bed rails accounted
for 4 of the 18 MRSA positive samples. The television remote and call bell were also
made of plastic and selected because they are frequently touched by the infected or
colonized patient. The television remote only accounted for 1 of the 18 MRSA positive
samples. On the other hand, the call bell accounted for 5 of the 18 MRSA positive
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samples. This was the most frequently contaminated surface, which confirms previous
research that showed high touch surfaces are more likely to be contaminated (Huslage
et al., 2010).
The bathroom doorknob was made of metal and only accounted for 2 of the 18
MRSA positive samples. A study by Oie et al., (2002) sampled door handles in a Japanese
hospital and found 19% of MRSA patient room door handles contained viable MRSA.
This study found a similar rate of pre-cleaning samples of the bathroom doorknobs with
17% positive.
The last surface was the bedside table, which did not produce any MRSA positive
samples. There are several possible explanations for this observation. The bedside
tables consisted of a composite wood and plastic material. The surface of this material
could be difficult to collect MRSA from, or perhaps survival was low on this material.
Additionally, this surface could be easier to clean or was more thoroughly cleaned by
staff.
Antimicrobial Susceptibility Profiles
One of the first studies to analyze the antimicrobial susceptibility profiles of
MRSA isolates was the SENTRY Antimicrobial Surveillance Program, which collected data
from 1997-1999, in the United States, Canada, Latin America, Europe, and the Western
Pacific region (Diekema et al., 2001). This study found the susceptibility rates of MRSA
isolates collected in the U.S. to be 64.5% for gentamicin, 96.3% for rifampicin, 11.4% for
ciprofloxacin, 84.6% for tetracycline, 20.8% for clindamycin, 6.3% for erythromycin, and
74.0% for trimethoprim-sulfamethoxazole (TMP-SMZ). Our study found comparable
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results for several of the antimicrobials including gentamicin (78%), rifampicin (100%),
ciprofloxacin (6%), tetracycline (78%), and erythromycin (11%). One difference observed
was the susceptibility rate of 39% for TMP-SMZ, which was much lower in our study
than rates in the U.S. (74.0%) and much more comparable to the rates seen in Latin
America (34.6%).
Another study analyzed the susceptibility of CA-MRSA strains to distinguish them
from HA-MRSA strains. Isolates were analyzed from patients with MRSA respiratory
infections, and the following susceptibility rates were found: vancomycin (100%),
gentamicin (86%), clindamycin (39%), quinolones (49%), and erythromycin (12%) (Almer
et al., 2002). Our results were similar for vancomycin (94%), gentamicin (78%),
clindamycin (56%), quinolones (44%), and erythromycin (11%) suggesting a majority of
our isolates may be CA-MRSA strains, but this must be confirmed by strain typing. This is
important information because CA-MRSA strains are usually more virulent and have
worse outcomes than HA-MRSA strains.
Study Limitations
There are several limitations to this study. The first limitation is only a relatively
small surface area in each room was sampled, which may have resulted in not
identifying all of the contamination. Second, the sampling method used may not have
been the most effective available. A recent paper found contact plates are more
efficient than swabs for recovering adsorbed cells (Obee, Griffith, Cooper, & Bennion,
2007). Third, there are no recognized environmental sampling standards making it
difficult to compare results to other publications. Fourth, the sample size (120 total
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samples) was small and only included two facilities. Lastly, this study included both
infected and colonized patients but did not differentiate between the two. Previous
studies have found colonized patients shed more bacteria into the environment (Boyce
et al., 1997), which could have impacted the results of this study.
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CHAPTER 6
CONCLUSION
The discovery of antibiotics has drastically reduced the number of people who
die from bacterial infections each year. However, the emergence of antibiotic resistant
bacteria continues to threaten the ability to treat these infections. Recently, antibiotic
resistant pathogens have been emerging in community settings, which may increase the
impact they have on populations. Additionally, several pathogens have become resistant
to multiple types of antimicrobials, making treatment more difficult.
One of the most concerning antimicrobial resistant bacteria is MRSA. Since it
emerged, it has spread throughout the world and now is present in both the community
and healthcare facilities. MRSA remains a leading cause of healthcare acquired
infections and results in about 460,000 hospitalizations and 19,000 deaths in the United
States each year (Klein et al., 2013; Klevens et al., 2007). This is an unacceptable burden
and a serious public health problem that requires solutions.
Contaminated environmental surfaces are a public health concern because, if
these surfaces are not properly cleaned, they become a potential source of transmission
of diseases such as MRSA. The current literature has demonstrated MRSA is present on
environmental surfaces in healthcare facilities where it can survive for long periods of
time and potentially cause infections. This study confirmed previous studies and
provided information on the prevalence of MRSA on environmental surfaces at an acute
care hospital and long-term care facility in southern Nevada.
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This study was designed to determine the prevalence of MRSA on five different
environmental surfaces pre and post terminal cleaning at an acute care hospital and a
long-term care facility. The results demonstrated that viable MRSA was present on
surfaces at both facilities. At the ACH, MRSA was present in 12% of pre-terminal
cleaning, and 0% of post-terminal cleaning samples. At the LTCF, MRSA was present in
43% of pre-terminal cleaning samples and 6% of post-terminal cleaning samples. The
location of the positive pre-cleaning samples included the floor (5), call bell (4), bed rail
(4), bathroom doorknob (2) and TV remote (1), and the positive post-cleaning samples
included the floor (1) and call bell (1). The floor, call bell, and bed rail may have been
more likely to be contaminated with MRSA because of the survival of MRSA on the
surface material and the proximity to the patient. Overall, the cleaning programs were
effective and only two post-cleaning samples yielded viable MRSA, which were most
likely caused by recontamination. The antibiotic susceptibility profile of the isolates
obtained in the study varied widely, but the majority (94%) was susceptible to
vancomycin, which is the main antibiotic used to treat MRSA infections.
The results of this study have several implications for future research. Overall,
the results suggested long-term care facilities can be contaminated with MRSA pre and
post-cleaning. Therefore, more resources should be used to further investigate longterm care facilities. Identifying the strain types for each of the isolates identified in this
study would also be useful. This would help identify which strains are present in each
facility and could be compared to other strains around the country and globe. In
addition, resources should be used to identify the most effective environmental
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cleaning programs and education programs for staff. Finally, future work should be
focused on establishing environmental sampling standards for healthcare facilities.
Currently, environmental sampling is rarely used in healthcare facilities unless there is
an outbreak. Nevertheless, it is nearly impossible to determine if a room is clean with
the naked eye because microorganisms can’t be seen and a room that looks clean may
be contaminated. It is clear that there is room for improvement in the cleaning of
healthcare facilities. One way to do this would be to conduct daily environmental
sampling, using large area surface sampling methods, of high touch surfaces, such as the
bed rail, floor and call bell in patient rooms. These samples could be analyzed for
antibiotic resistant bacteria, such as MRSA, to ensure that rooms are adequately
cleaned. Implementing environmental monitoring in all healthcare facilities would help
improve cleaning programs and reduce transmission of bacteria such as MRSA.
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APPENDIX A. INTERNAL POSITIVE CONTROL PCR RESULTS
IPC Results
Real time PCR analysis of environmental samples for the presence of the mecA
gene.

Mean CT value
Facility
ACH
ACH
ACH
LTCF

Sample ID
4G
4H
5F
6G

LTCF
LTCF
LTCF
LTCF

6I
7F
7G
7H

LTCF
LTCF
LTCF
LTCF
LTCF
LTCF

7I
8H
11F
11G
11H
12F
NTC
NAC
MRSA +

Sample Location
Bed Rail
TV Remote
Floor
Bed Rail
Bathroom
doorknob
Floor
Bed Rail
Call Bell
Bathroom
doorknob
Call Bell
Floor
Bed Rail
Call Bell
Floor

Pre or Postcleaning
Pre
Pre
Pre
Pre

IPC
30.55
30.55
34.34
32.54

mecA
UD
UD
UD
UD

Pre
Pre
Pre
Pre

29.87
30.10
30.21
30.12

UD
UD
UD
UD

Pre
Pre
Pre
Pre
Pre
Pre

30.17
30.44
UD
37.02
38.93
38.79
29.64
UD
UD

UD
UD
UD
UD
UD
UD
UD
UD
20.53

NTC = No template control
NAC = No Amplification Control
UD = Undetermined
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Appendix B. Corresponding Post-Cleaning Sample PCR Results
Real time PCR analysis of environmental samples for the presence of the mecA gene
at two concentrations.

Mean CT value
DNA Concentration
Facility
ACH
ACH
ACH
LTCF

Sample ID
4G
4H
5F
6G

LTCF
LTCF
LTCF
LTCF

6I
7F
7G
7H

LTCF
7I
LTCF
8H
LTCF
11F
LTCF
11G
LTCF
11H
LTCF
12F
UD = Undetermined

Sample Location
Bed Rail
TV Remote
Floor
Bed Rail
Bathroom
doorknob
Floor
Bed Rail
Call Bell
Bathroom
doorknob
Call Bell
Floor
Bed Rail
Call Bell
Floor

Pre or Postcleaning
Pre
Pre
Pre
Pre

Undiluted
UD
UD
UD
UD

10-1
UD
UD
UD
UD

10-2
UD
UD
UD
UD

Pre
Pre
Pre
Pre

UD
UD
UD
UD

UD
UD
UD
UD

UD
UD
UD
UD

Pre
Pre
Pre
Pre
Pre
Pre

UD
UD
UD
UD
UD
UD

UD
UD
UD
UD
UD
UD

UD
UD
UD
UD
UD
UD
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+
+
R
R
S
S
S
S
R
S
S
S
S
S
S
S
S
S
S
S

-

S
S

S

S
S
S
S
S
S
S
S

R

4C
TV
remote
Pre

+
+
R
R
S
R
R
R

4B
Bed
rail
Pre

S

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
I
R
R
I

Pre

Floor

5A

R

S
S
S
S
S
S
S
S

S

R
R

-

+
+
R
R
S
R
R
I

Pre

Floor

6A

R

S
S
S
S
S
S
S
S

S

S
S

-

+
+
R
R
S
R
R
I

6B
Bed
rail
Pre

R

S
S
I
S
R
S
S
S

S

R
R

+

+
+
R
R
S
R
R
R

6C
Call
Bell
Pre

R

S
S
S
S
R
S
S
S

S

R
R

+

+
+
R
R
S
R
R
R

6D
Bathroom
Doorknob
Pre

S

S
S
S
S
S
S
S
S

S

R
R

+

+
+
R
R
S
R
R
R

Post

Floor

6F

R

S
S
S
S
S
S
S
S

S

R
R

+

+
+
R
R
S
R
R
I

6H
Bed
Rail
Post

R

S
S
S
S
S
S
S
S

S

R
R

-

+
+
R
R
I
R
R
R

Pre

Floor

7A

R

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
S
R
R
I

7B
Bed
rail
Pre

R

S
S
S
S
R
S
I
S

S

R
R

-

+
+
R
R
S
R
R
R

7C
Call
bell
Pre

S = susceptible; R = resistant; I = intermediate susceptibility; - represents negative result; + represents positive result
Isolates were analyzed by VITEK® 2 Compact using the AST-GP71 Card.

Antimicrobial Agent
Beta-Lactamase
Cefoxitin Screen
Benzylpenicillin
Oxacillin
Gentamicin
Ciprofloxacin
Levofloxacin
Moxifloxacin
Inducible Clindamycin
Resistance
Erythromycin
Clindamycin
Quinupristin/
Dalfopristin
Linezolid
Daptomycin
Vancomycin
Minocycline
Tetracycline
Tigecycline
Nitrofurantoin
Rifampicin
Trimethoprim/
Sulfamethoxazole

Pre or post clean

Location

Sample ID

ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF ENVIRONMENTAL MRSA ISOLATES

R

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
I
R
R
I

7D
Bathroom
Doorknob
Pre

S

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
R
R
R
I

8C
Call
bell
Pre

S

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
S
R
R
R

Pre

Floor

11A

S

S
S
S
S
S
S
S
S

S

R
R

-

+
+
R
R
S
R
R
R

11B
Bed
rail
Pre

R

S
S
S
S
R
S
S
S

S

R
S

-

+
+
R
R
S
R
R
R

11C
Call
bell
Pre

S

S
S
S
S
S
S
S
S

S

R
S

-

+
+
R
R
S
R
R
R

Pre

Floor

12A

APPENDIX C. ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF ENVIRONMENTAL MRSA

ISOLATES

APPENDIX D. DISINFECTANTS USED BY EACH FACILITIY
A. Disinfectant used at the Long-Term Care Facility
Brand Name: 3M™QUAT DISINFECTANT CLEANER Ready-to-Use (Product No. 5, Twist 'n
FillTM System)
EPA Registration Number: 6836-78-10350

Product: LONZA FORMULATION R-82 (EPA, 2009)
EPA Reg#: 6836-78
Registrant: LONZA INC
Approval Date: 06/19/2007
Active Ingredients:
Dioctyl dimethyl ammonium chloride 2.604%
Alkyl* dimethyl benzyl ammonium chloride*(50%C14, 40%C12, 10%C16) 8.68%
Didecyl dimethyl ammonium chloride 3.906%
Octyl decyl dimethyl ammonium chloride 6.51%

B. Disinfectant used at the Acute Care Hospital
Brand Name: Ecolab’s A-456 II Disinfectant Cleaner
EPA Registration: 6836-78-1677

Product: LONZA FORMULATION R-82 (EPA, 2009)
EPA Reg#: 6836-78
Registrant: LONZA INC
Approval Date: 06/19/2007
Active Ingredients:
Dioctyl dimethyl ammonium chloride 2.604%
Alkyl* dimethyl benzyl ammonium chloride*(50%C14, 40%C12, 10%C16) 8.68%
Didecyl dimethyl ammonium chloride 3.906%
Octyl decyl dimethyl ammonium chloride 6.51%
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